authored by Joshua I Barzilay*
Background
Albuminuria - the presence of more than 30 mg of alumin per one gram of creatinine in the urine - is highly prevalent in older adults. Based on data from the NHANES III study, more than 20% of adults over the age of 70 years have albuminuria, while among similarly aged adults with diabetes the prevalence reaches 40% [1,2]. To date, most studies have examined albuminuria as a risk factor for cardiovascular disease. We too have found albuminuria to be associated with a 70-80% increased prevalence of cardiovascular disease [3] and a doubling of mortality risk (mostly cardiovascular in nature) [4] as compared to older people without microalbuminuria.
More recently, we and others have shown that albuminuria is associated with other diseases of older age. The two most outstanding diseases of older age associated with albuminuria are hip fractures and dementia. In one study of ours [5], a doubling of albuminuria was significantly associated with hip fracture risk in women (hazard ratio, 1.12, 95 % CI, 1.001-1.25), but not in men. In two other studies, we found a borderline lower bone mineral density in association with albuminuria in men [5, 6]. We also reported that participants with baseline albuminuria had a significantly increased risk of hip fracture compared with participants without albuminuria (adjusted hazard ratio=1.36 [1.01, 1.84], P=0.05) [7]. Last, it is known that up to 40-50% of people with hip fractures have cognitive impairment (such as dementia or mild cognitive impairment [a possible precursor of dementia). In our analyses we found that the association of cognitive impairment with hip fracture risk was attenuated with adjustment for the presence of albuminuria [8]. Stated differently, albuminuria played a role in mediating the association of hip fracture risk with cognitive impairment. Given the above findings, it would appear that albuminuria is more than a disorder of the glomerulus or a cardio-renal risk factor.
Several studies have shown albuminuria to be related to other disorders of aging. These include reduced physical performance, as measured by gait speed and grip strength [9]; dementia [10]; reduced lung function, as measured by one second forced expiratory volume [11]; microvascular cardiomyopathy [12]; abnormal reactivity of small [13] and large blood vessels [14]; and abnormal retinal findings in people with diabetes [15]. Taken together, these findings suggest that albuminuria may be an indicator of enhanced physiological aging beyond its known association with cardiovascular risk, and a possible marker of a systemic functional disorder of the microvasculature [16].
Present Study
We reasoned that if albuminuria is indeed a marker of aging or of enhanced susceptibility to illness, then hospitalization rates would be higher in people with albuminuria as compared to people without albuminuria. In addition, we hypothesized that rates of hospitalization would be increased as well for a wide variety of disorders, especially in certain domains of aging—for example, heart failure, injury, cancer and infection. Finally, given the adverse association of diabetes on health, we hypothesized that people with albuminuria and diabetes would have a higher rate of hospitalization than people with albuminuria but without diabetes. To do such an analysis, we examined the Cardiovascular Health Study (CHS) data set. CHS is a follow up study of nearly 6000 Caucasian and African American adults (age >65 years at baseline) from four US research centers who have been passively followed for health outcomes over several decades. The cohort is well characterized and has served as a source for more than 1500 academic papers. Using incident hospitalization rates as a measure of outcome, we found albuminuria to have a pervasive and deleterious association on the health of older adults across a broad range of diagnoses. Hospitalization rates were 39% higher among people with albuminuria compared to people without albuminuria, even after adjustment for hypertension and diabetes (the main determinants of albuminuria), and adjustment for concomitant estimated glomerular filtration rate. The number of hospital days was increased by ~60% as well. Circulatory disorders (e.g., heart failure) accounted for the largest number of hospitalizations (~30%). Most hospitalizations, however, were not for circulatory disorders. Infectious, endocrine (e.g., diabetes), injury and respiratory (e.g., pneumonia) hospitalizations were increased 40- 90%. Cancer risks were also increased, but not significantly so. Genitourinary disorders, in particular, were increased by ~40% in men and ~75% in women. Diseases of the male genital organs (ICD 9 codes 600.0-608.0) were increased. Of interest, the presence of diabetes did not enhance the risk of being hospitalized for any of these disorders. From this latter finding it may be deduced that the effect of diabetes on hospitalization risk is mediated in large part through its association with albuminuria, not from diabetes per se. Also, of interest, was the fact that albuminuria did not significantly increase the risk of hospitalization for chronic kidney disease, though it did have a statistically significant association with acute kidney injury. For more specifics, the reader is referred to our article (see reference 1).
Conclusion
In conclusion, there are two take away messages from our study for the urologist and the nephrologist. One, albuminuria is most likely a manifestation of a systemic disorder that impacts the health of older adults. It is not just a renal microvascular disorder. Second, albuminuria is a risk factor for hospitalization. Additional attention to people with albuminuria, to optimize their health, may lead to cost savings.
To read more about this article....Open access Journal of Annals of Urology & Nephrology
To know more about our Journals....Iris Publishers
No comments:
Post a Comment